Back to top

medical: Archive

Aparajita Dutta

Betting on a Boom: 3 Healthcare ETFs for 2026 and Beyond

After a late-2025 rebound eased policy fears, healthcare ETFs like IXJ are gaining attention as investors position for a sector comeback in 2026.

AZNPositive Net Change LLYNegative Net Change XLVNegative Net Change VHTNegative Net Change IXJNegative Net Change

Zacks Equity Research

PacBio Stock Dips Post Latest Launch to Expand Multiomics Capabilities

PACB introduces CiFi, a new sequencing method designed to expand multiomics capabilities without added hardware.

BSXNegative Net Change CAHNegative Net Change IDXXPositive Net Change PACBNegative Net Change

Zacks Equity Research

SENS Stock Up as Eversense 365 Enters AID Market With twiist System

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin delivery system.

BSXNegative Net Change ISRGPositive Net Change SENSPositive Net Change MEDPNegative Net Change

Zacks Equity Research

J&J Strikes Drug Pricing Deal With Trump, Gets Tariff Reprieve

JNJ cuts U.S. drug prices under a Trump deal, gains a tariff reprieve, and accelerates a $55 billion push to expand domestic manufacturing.

AZNPositive Net Change JNJNegative Net Change LLYNegative Net Change ABBVNegative Net Change

Sanghamitra Saha

Here's Why Biotech ETFs Are Rallying Hard

Biotech rally gains steam on valuations, rate cuts, FDA wins & M&A. IBB, XBI, CANC and IDNA are ETFs near one-year highs.

IBBPositive Net Change SPYPositive Net Change XBIPositive Net Change IDNAPositive Net Change CANCPositive Net Change

Zacks Equity Research

VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug

Viking Therapeutics completes enrollment in a phase I maintenance study of VK2735, testing flexible oral and injectable dosing after initial weight loss in obese adults.

NVOPositive Net Change LLYNegative Net Change VKTXPositive Net Change GPCRPositive Net Change

Indrajit Bandyopadhyay

3 MedTech Stocks That Crushed the S&P 500 Over the Past Year

TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.

CAHNegative Net Change TMDXNegative Net Change KRMDNegative Net Change

Zacks Equity Research

Bayer Accelerates Growth With siRNA, AI Deals and Pipeline Progress

Bayer AG enters into collaborations to develop a heart-targeted siRNA therapy and AI technology, expanding its push into next-gen genetic medicines.

JNJNegative Net Change BAYRYNegative Net Change FOLDNo Net Change CRMDPositive Net Change

Ekta Bagri

BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock?

BMY shares have surged in the past six months, driven by Opdivo, Reblozyl and a guidance raise, as growth drugs offset mounting generic pressure

BMYNegative Net Change PFEPositive Net Change MRKNegative Net Change BNTXPositive Net Change

Indrajit Bandyopadhyay

Can da Vinci 5 Expand Intuitive Surgical's TAM Beyond Core Surgeries?

ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.

JNJNegative Net Change MDTNegative Net Change ISRGPositive Net Change

Zacks Equity Research

Is it the Right Time to Add STERIS Stock to Your Portfolio?

STE is buoyed by strong Healthcare and AST growth, solid margins and balance sheet strength, even as macro pressures and competition loom.

BSXNegative Net Change DGXNegative Net Change STENegative Net Change PAHCNegative Net Change

Moumi Mondal

3 Medical Service Industry Stocks Set to Tackle Workforce Challenges

Medical services stocks like MEDP, EHAB and PGNY benefit from tech-driven care models even as staffing gaps pressure margins.

MEDPNegative Net Change PGNYNegative Net Change EHABNegative Net Change

Zacks Equity Research

Do Options Traders Know Something About Avadel Pharmaceuticals Stock We Don't?

Investors need to pay close attention to Avadel Pharmaceuticals stock based on the movements in the options market lately.

AVDLPositive Net Change

Zacks Equity Research

Tempus AI Stock Surges 82.4% in a Year: What's Driving It?

TEM shares are up 82.4% in a year as Genomics revenues surge, Data & Services scale, FDA clearances and EBITDA turns positive.

DGXNegative Net Change CRLPositive Net Change PAHCNegative Net Change TEMNegative Net Change

Sundeep Ganoria

Here's What We Expect From AbbVie's Immunology Segment in Q4

ABBV's Q4 outlook hinges on surging Skyrizi and Rinvoq demand, as investors watch immunology sales to offset Humira's past loss of exclusivity.

JNJNegative Net Change LLYNegative Net Change ABBVNegative Net Change

Zacks Equity Research

Zacks Industry Outlook Highlights Tenet Healthcare, Universal Health Services and Community Health Systems

Tenet Healthcare stands out as hospitals battle rising costs, care migration, and margin pressure across a strained industry.

UHSNegative Net Change THCNegative Net Change CYHNegative Net Change

Zacks Equity Research

GSK's Chronic Hepatitis B Drug Meets Goals in Two Late-Stage Studies

GSK's bepirovirsen hit primary endpoints in two phase III trials, boosting hopes for a functional cure in chronic hepatitis B patients.

GSKPositive Net Change CRMDPositive Net Change IONSNegative Net Change KROSPositive Net Change

Zacks Equity Research

CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

Centene expands its Medicaid strategy by partnering with Cityblock Health to serve 10,000 Illinois members with 24/7 wrap-around care.

RIGLNegative Net Change CNCNegative Net Change CRMDPositive Net Change EXASPositive Net Change

Debanjana Dey

Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?

HIMS expands into Canada and the U.K. while revenue and subscribers grow. However, margins and execution raise concerns.

TDOCNegative Net Change HIMSNegative Net Change DOCSPositive Net Change

Zacks Equity Research

INGN Stock Gains Post Latest Launch to Expand Respiratory Care Suite

Inogen launches Aurora CPAP masks to expand its respiratory care suite and enter the growing sleep apnea market.

BSXNegative Net Change CAHNegative Net Change IDXXPositive Net Change INGNNegative Net Change

Zacks Equity Research

KRYS Stock Surges 57% in a Year: More Upside Potential in 2026?

Shares of Krystal Biotech soar 57% in a year as strong Vyjuvek uptake and steady pipeline progress continue to push the stock higher.

FOLDNo Net Change CRMDPositive Net Change KRYSPositive Net Change

Zacks Equity Research

The Zacks Analyst Blog Highlights Micron Technology, Roche and UnitedHealth

Micron Technology, Roche and UnitedHealth highlight diverging opportunities across technology, pharmaceuticals and managed care.

RHHBYPositive Net Change UNHNegative Net Change MUPositive Net Change

Zacks Equity Research

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for 2026.

IRWDPositive Net Change NKTRNegative Net Change RIGLNegative Net Change SLNONegative Net Change MRKRNegative Net Change

Ahan Chakraborty

Is LLY's Ventyx Deal Another Attempt at Diversification Beyond GLP-1?

Eli Lilly ramps up M&A activity, adding Ventyx and other assets to diversify beyond obesity as competition in the GLP-1 space intensifies.

PFEPositive Net Change NVOPositive Net Change LLYNegative Net Change VTYXNegative Net Change

Kaibalya Pravo Dey

Hospital Industry Reshaping Under Strain: 3 Stocks Worth Watching

THC, UHS and CYH are showing strength through outpatient focus and efficiency-improving efforts, despite hospital industry headwinds.

THCNegative Net Change UHSNegative Net Change CYHNegative Net Change